COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
[Selected press releases/announcements from organizations from WHO EUL/PQ listing above and other organizations]
AstraZeneca
Press Releases – No new digest announcements identified
Bharat Biotech
Press Releases – No new company announcements identified
BioCubaFarma – Cuba
Últimas Noticias – Website not leading at inquiry
Biological E
News – No new digest announcements identified
Biontech
Press Releases
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
14 April 2022
CanSinoBIO
News – Website not responding at inquiry
CIGB
Latest News – No new digest announcements identified
Cinagen
Recent News – No new digest announcements identified
Clover Biopharmaceuticals – China
News – No new digest announcements identified
Curevac [Bayer Ag – Germany]
News
April 11, 2022
CureVac and GSK Enter into Pandemic Preparedness Contract with German Government
German government reserves domestic manufacturing capacity until 2029 to ensure rapid access to mRNA vaccines developed by CureVac and GSK
Five-year contract enables production of up to 80 million vaccine doses at short notice in case of a public health emergency, contributing to increased pandemic preparedness
Gamaleya National Center
Latest News and Events – See Russia below.
IMBCAMS, China
Home – Website not responding at inquiry
Janssen/JNJ
Press Releases – No new digest announcements identified
Medicago
Media – No new digest announcements identified
Moderna
Press Releases
11 April, 2022
Moderna Announces First Participants Dosed in Phase 1/2 Study with mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccine Candidates
Nanogen
News – No new digest announcements identified
Novavax
Press Releases
Apr 13, 2022
Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine
Pfizer
Recent Press Releases
04.14.2022
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age
R-Pharm
https://rpharm-us.com/index.php
[No news or media page identified]
Sanofi Pasteur
Press Releases – No new digest announcements identified
Serum Institute of India
NEWS & ANNOUNCEMENTS – No new digest announcements identified
Shifa Pharmed [Iran]
http://shafapharmed.com/
No news page identified.
Sinopharm/WIBPBIBP
News – No new digest announcements identified
Sinovac
Press Releases – No new digest announcements identified
Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified
WestVac Biopharma
Media – No new digest announcements identified
Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]
::::::
GSK
Press releases for media – No new digest announcements identified
Merck
News releases
Merck Announces U.S. FDA has Granted Breakthrough Therapy Designation for V116, the Company’s Investigational 21-Valent Pneumococcal Conjugate Vaccine, for the Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
April 14, 2022
Novartis
News – No new digest announcements identified
SK Biosciences
Press releases –
SK bioscience Initiates Clinical Development of Antiviral Nasal Spray for Prevention of COVID-19
SK began developing an innovative technology to prevent viral infections and relieve symptoms through intranasal spray
The spray is expected to be used as the first line of defense to prevent virus spread before vaccine development
The project is being funded by the Bill & Melinda Gates Foundation through a grant to IAVI and a subgrant to SK bioscience
2022.04.13
Valneva
Press Releases
April 14, 2022
Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine
vaccines and global health :: ethics and policy 